Preanalytic Variables in Special Coagulation Testing
Clinical Implications
Normal Hematocrit and High Hematocrit

October 2008
This slide shows a cartoon of a specimen collection tube containing citrate anticoagulant. This is just a diagrammatic representation.
When a patient sample is collected the citrate anticoagulant will typically be mixed in and not visible as a discrete layer. The amount of citrate anticoagulant present in commercially available collection tubes is calculated to result in a ratio of 1 part anticoagulant to 9 parts whole blood or 1 part anticoagulant to 5 parts of plasma, as shown.
The tube shown on the left represents a typical blood sample from a patient with a normal hematocrit. The tube on the right, however, represents a sample from a patient with an elevated hematocrit, such as the patient I have just described.
In this situation, even the increase hematocrit there is a relative reduction in the amount plasma collected in the tube, and therefore, there is a relative excess of anticoagulant which elates an excessive amount of calcium.
Normal and High Hematocrit |
Jump to section:
- Introduction
- Variables Affecting Test Results
- Preanalytic Variables Affecting Coagulation Testing
- Special Coagulation Test Algorithms
- Case History
- Preprocedure Coagulation Tests
- PT and aPTT Diagram
- Normal Hematocrit and High Hematocrit
- Preprocedure Coagulation Tests
- Case Conclusion
- Case Example
- Repeat Testing With Fresh Sample
- Intrinsic and Extrinsic Diagram
- Clotted Specimen: Definition of Clotted Specimen
- Significance of Clotted Specimen
- Significance of Clotted Specimen
- Preanalytic Factors Affecting Testing Results: Clotted Specimen
- Scope of the Problem
- Event Capture Tool
- Clotted Specimens as a Percentage of Test Volume
- Clotted Specimens 2007
- Clinical Laboratory Standards Institute
- Rejection of Specimen: Impact
- Causes of Clotted Specimen
- Steps Towards Reducing Clotted Specimens
- Conclusion
- Questions?


